Trial Profile
Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 01 Aug 2019 Results evaluating the efficacy and safety of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis Bpublished in the Medicine
- 12 Mar 2019 Planned number of patients changed from 260 to 360.
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases